ORG-25935, the Glossary
ORG-25935, also known as SCH-900435 is a synthetic drug developed by Organon International, which acts as a selective inhibitor of the glycine transporter GlyT-1.[1]
Table of Contents
9 relations: Alcoholic beverage, Analgesic, Anticonvulsant, Antipsychotic, Glycine reuptake inhibitor, Glycine transporter, Ketamine, Organon & Co., Sodium- and chloride-dependent glycine transporter 1.
- Glycine reuptake inhibitors
Alcoholic beverage
An alcoholic beverage (also called an adult beverage, alcoholic drink, strong drink, or simply a drink) is a beverage containing alcohol.
See ORG-25935 and Alcoholic beverage
Analgesic
An analgesic drug, also called simply an analgesic, antalgic, pain reliever, or painkiller, is any member of the group of drugs used for pain management.
Anticonvulsant
Anticonvulsants (also known as antiepileptic drugs, antiseizure drugs, or anti-seizure medications (ASM)) are a diverse group of pharmacological agents used in the treatment of epileptic seizures.
See ORG-25935 and Anticonvulsant
Antipsychotic
Antipsychotics, previously known as neuroleptics and major tranquilizers, are a class of psychotropic medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia but also in a range of other psychotic disorders.
See ORG-25935 and Antipsychotic
Glycine reuptake inhibitor
A glycine reuptake inhibitor (GRI) is a type of drug which inhibits the reuptake of the neurotransmitter glycine by blocking one or more of the glycine transporters (GlyTs). ORG-25935 and glycine reuptake inhibitor are glycine reuptake inhibitors and Nervous system drug stubs.
See ORG-25935 and Glycine reuptake inhibitor
Glycine transporter
Glycine transporters (GlyTs) are plasmalemmal neurotransmitter transporters.
See ORG-25935 and Glycine transporter
Ketamine
Ketamine is a dissociative anesthetic used medically for induction and maintenance of anesthesia.
Organon & Co.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey.
See ORG-25935 and Organon & Co.
Sodium- and chloride-dependent glycine transporter 1
Sodium- and chloride-dependent glycine transporter 1, also known as glycine transporter 1, is a protein that in humans is encoded by the SLC6A9 gene which is promising therapeutic target for treatment of diabetes and obesity.
See ORG-25935 and Sodium- and chloride-dependent glycine transporter 1
See also
Glycine reuptake inhibitors
- Alcohol (drug)
- Amoxapine
- Bitopertin
- Glycine reuptake inhibitor
- Iclepertin
- N-Arachidonylglycine
- ORG-25935
- Opiranserin
- Pesampator
- Pharmacology of ethanol
- Sarcosine
References
[1] https://en.wikipedia.org/wiki/ORG-25935
Also known as Org 25935.